(A and B) ChIP-qPCR analysis of HSF2 binding to the indicated KSHV genomic regions expressed as % of input in KSHV infected latent (A) and lytic (B) cells. by Lorenza Cutrone (21144285)

Subjects:

Primers used in RTqPCR. by Lorenza Cutrone (21144285)

Subjects:

HSF2 expression sustains KSHV infection in KLEC. by Lorenza Cutrone (21144285)

Subjects:

HSF2 binds to the BZLF1 promoter and remodels the chromatin locally. by Lorenza Cutrone (21144285)

Subjects:

(A–D) Representative immunoblots for the reporter assays shown in Fig 4A–D. by Lorenza Cutrone (21144285)

Subjects:

HSF2 is a positive regulator of EBV spontaneous lytic cycle in gastric epithelial cells. by Lorenza Cutrone (21144285)

Subjects:

HEK.219 cells were treated with the indicated siRNAs for 24h. by Lorenza Cutrone (21144285)

Subjects:

HSF2 regulates ORF50 expression in an RTA independent manner. by Lorenza Cutrone (21144285)

Subjects:

HSF2 is degraded during KSHV lytic reactivation. by Lorenza Cutrone (21144285)

Subjects:

(A) Confocal representative images and (B) quantification of the H3me3K4 integrated intensity in n > 100 cells in iSLK.219 either latent or induced to the lytic cycle with doxycycl... by Lorenza Cutrone (21144285)

Subjects:

HSF2 regulates lytic gene expression in latency and during the lytic phase. by Lorenza Cutrone (21144285)

Subjects:

HSF2 binds the ORF50 promoter and remodels the local chromatin landscape. by Lorenza Cutrone (21144285)

Subjects:

Table 1_Prognostic significance of fibrinogen levels in sepsis-associated acute kidney injury: unveiling a nonlinear relationship and clinical implications.docx by Manqin Chen (20129541)

“…</p>Conclusion<p>In patients with SA-AKI, a non-linear relationship was identified between fibrinogen levels and 28-day mortality. Particularly, when their fibrinogen levels were less than 1.6 g/l, a concomitant decrease in 28-day mortality was observed as fibrinogen levels increased.…”

Regional differences in percentage changes of N07BA drug prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Hypnotic and sedative (N05C) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N05B prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (females). by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N05C prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N06A prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Drugs used in addictive disorders (N07B) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects: